Skip to main content
SpringerLink
Log in

Augenwachstum von Kindern, die sich einer Myopiekontrollbehandlung unterziehen, im Vergleich zu emmetropischem Augenwachstum

Eye growth of children undergoing myopia control treatment compared with emmetropic eye growth. German version

  • Leserbriefe
  • Published:
Der Ophthalmologe Aims and scope Submit manuscript

The Original Article was published on 08 July 2021

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Kaymak H et al (2021) Myopia treatment and prophylaxis with defocus incorporated multiple segments spectacle lenses. Ophthalmologe 118(12):1280–1286. https://doi.org/10.1007/s00347-021-01452-y

    Article  PubMed  PubMed Central  Google Scholar 

  2. Lam CSY et al (2020) Defocus incorporated multiple segments (DIMS) spectacle lenses slow myopia progression: a 2‑year randomised clinical trial. Br J Ophthalmol 104(3):363–368

    Article  Google Scholar 

  3. Truckenbrod C et al (2021) Longitudinal analysis of axial length growth in a German cohort of healthy children and adolescents. Ophthalmic Physiol Opt 41(3):532–540

    Article  Google Scholar 

  4. Walline JJ et al (2020) Effect of high add power, medium add power, or single-vision contact lenses on myopia progression in children: the BLINK randomized clinical trial. JAMA 324(6):571–580

    Article  Google Scholar 

  5. Yam JC et al (2020) Two-year clinical trial of the low-concentration atropine for myopia progression (LAMP) study: phase 2 report. Ophthalmology 127(7):910–919

    Article  Google Scholar 

  6. Cho P, Cheung SW (2012) Retardation of myopia in orthokeratology (ROMIO) study: a 2‑year randomized clinical trial. Invest Ophthalmol Vis Sci 53(11):7077–7085

    Article  Google Scholar 

  7. Chamberlain P et al (2021) Measured and predicted axial elongation in the Misight 1 day clinical trial—6 year results. Invest Ophthalmol Vis Sci 62(8):2342–2342

    Google Scholar 

  8. Wong HB et al (2010) Ocular component growth curves among Singaporean children with different refractive error status. Invest Ophthalmol Vis Sci 51(3):1341–1347

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. CooperVision Inc., 5870 Stoneridge Drive, Suite 1, 94588, Pleasanton, CA, USA

    David Hammond, Paul Chamberlain, Baskar Arumugam & Arthur Bradley

Authors
  1. David Hammond
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul Chamberlain
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Baskar Arumugam
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Arthur Bradley
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David Hammond.

Ethics declarations

Interessenkonflikt

D. Hammond, P. Chamberlain, B. Arumugam und A. Bradley sind als Mitarbeiter von CooperVision Int. tätig.

Additional information

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hammond, D., Chamberlain, P., Arumugam, B. et al. Augenwachstum von Kindern, die sich einer Myopiekontrollbehandlung unterziehen, im Vergleich zu emmetropischem Augenwachstum. Ophthalmologe 119, 525–527 (2022). https://doi.org/10.1007/s00347-021-01570-7

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00347-021-01570-7

Search

Navigation